Chunlin Zhuang

5.9k total citations · 2 hit papers
159 papers, 4.7k citations indexed

About

Chunlin Zhuang is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Chunlin Zhuang has authored 159 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Molecular Biology, 47 papers in Organic Chemistry and 26 papers in Oncology. Recurrent topics in Chunlin Zhuang's work include Cell death mechanisms and regulation (29 papers), HIV/AIDS drug development and treatment (22 papers) and Genomics, phytochemicals, and oxidative stress (19 papers). Chunlin Zhuang is often cited by papers focused on Cell death mechanisms and regulation (29 papers), HIV/AIDS drug development and treatment (22 papers) and Genomics, phytochemicals, and oxidative stress (19 papers). Chunlin Zhuang collaborates with scholars based in China, United States and Belgium. Chunlin Zhuang's co-authors include Zhenyuan Miao, Chengguo Xing, Chunquan Sheng, Wannian Zhang, Wen Zhang, Wannian Zhang, Fen‐Er Chen, Erik De Clercq, Christophe Pannecouque and Zhuo Qu and has published in prestigious journals such as Chemical Reviews, SHILAP Revista de lepidopterología and Journal of Agricultural and Food Chemistry.

In The Last Decade

Chunlin Zhuang

150 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chalcone: A Privileged Structure in Medicinal Chemistry

2017 1.1k citations Chunlin Zhuang, Wen Zhang et al. Chemical Reviews profile →
Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis

2022 138 citations Chunlin Zhuang, Pei Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chunlin Zhuang China	33	2.4k	1.7k	519	519	500	159	4.7k
Diogo Santos‐Martins United States	16	2.7k 1.1×	1.0k 0.6×	474 0.9×	421 0.8×	329 0.7×	30	5.0k
John A. Beutler United States	41	3.0k 1.2×	1.7k 1.0×	1.1k 2.1×	505 1.0×	389 0.8×	180	5.6k
Liangren Zhang China	39	2.8k 1.1×	2.4k 1.3×	300 0.6×	456 0.9×	239 0.5×	236	6.2k
Romano Silvestri Italy	39	1.6k 0.7×	3.3k 1.9×	549 1.1×	322 0.6×	793 1.6×	191	5.5k
Hsing‐Pang Hsieh Taiwan	44	2.3k 1.0×	2.1k 1.2×	454 0.9×	832 1.6×	638 1.3×	152	5.3k
Masami Otsuka Japan	29	1.6k 0.7×	1.5k 0.8×	232 0.4×	531 1.0×	236 0.5×	170	3.3k
Guoqiang Dong China	44	3.1k 1.3×	2.1k 1.2×	403 0.8×	1.1k 2.2×	502 1.0×	149	5.3k
Xiao Ding China	28	1.2k 0.5×	745 0.4×	245 0.5×	275 0.5×	408 0.8×	118	2.7k
Giuseppe La Regina Italy	33	945 0.4×	2.1k 1.2×	265 0.5×	217 0.4×	469 0.9×	105	3.4k
Hyung Ryong Moon South Korea	37	1.9k 0.8×	1.4k 0.8×	247 0.5×	219 0.4×	399 0.8×	235	4.8k

Countries citing papers authored by Chunlin Zhuang

Since Specialization

Citations

This map shows the geographic impact of Chunlin Zhuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunlin Zhuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunlin Zhuang more than expected).

Fields of papers citing papers by Chunlin Zhuang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunlin Zhuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunlin Zhuang. The network helps show where Chunlin Zhuang may publish in the future.

Co-authorship network of co-authors of Chunlin Zhuang

This figure shows the co-authorship network connecting the top 25 collaborators of Chunlin Zhuang. A scholar is included among the top collaborators of Chunlin Zhuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunlin Zhuang. Chunlin Zhuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cai, Yue, Hui Dai, Chunlin Zhuang, et al.. (2025). Semiheterogeneous Intrinsic FeTiO₃-Photoredox/Ph₃N Dual-Catalyzed Fluoroalkylation of N-Heteroarenes with Alkenes and R_fSO₂Cl. The Journal of Organic Chemistry. 90(41). 14786–14795. 4 indexed citations

Jiang, Jun, Chunlin Zhuang, Li‐Juan Ou, et al.. (2025). Decatungstate-photocatalyzed heterogeneous direct benzylation of N-heterocycles with benzaldehydes. Chinese Chemical Letters. 37(4). 111776–111776. 4 indexed citations

Wang, Rui & Chunlin Zhuang. (2025). Graph neural networks driven acceleration in drug discovery. Acta Pharmaceutica Sinica B. 15(12). 6163–6177. 1 indexed citations

Li, Ningbo, Jia-Cheng Hou, Chunlin Zhuang, et al.. (2025). Nd@g-C3N4 dual-functional photosynthesis and antitumor activities of 3-fluoroalkylated quinoxalin-2(1H)-ones. Chinese Chemical Letters. 36(12). 111402–111402. 12 indexed citations

Dai, Pengcheng, et al.. (2025). Advances in MLKL-targeted inhibitors and PROTACs for necroptosis therapeutics. Bioorganic & Medicinal Chemistry. 128. 118246–118246.

He, Yuan, Tingting Yang, Jiao Li, et al.. (2024). Identification of a marine‐derived sesquiterpenoid, Compound‐8, that inhibits tumour necrosis factor‐induced cell death by blocking complex II assembly. British Journal of Pharmacology. 181(15). 2443–2458. 7 indexed citations

Liu, Ning, Zhuo Huang, Xiaodong Peng, et al.. (2024). Research Progress on NMDA Receptor Enhancement Drugs for the Treatment of Depressive Disorder. CNS Drugs. 38(12). 985–1002. 2 indexed citations

Zhang, Juan, Mengqi Ma, Jinhe Zhang, et al.. (2023). Discovery of marine phidianidine-based Nrf2 activators and their potential against oxLDL- and HG-induced injury in HUVECs. Bioorganic & Medicinal Chemistry Letters. 95. 129468–129468. 1 indexed citations

Zhao, Wenli, Ying Shi, Jianqiang Yu, et al.. (2023). Diallyl disulfide blocks cigarette carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis via activation of Nrf2 antioxidant system and suppression of NF-κB inflammatory response. SSRN Electronic Journal. 1 indexed citations

10.

Yu, Jianqiang, et al.. (2023). Dietary Phytochemicals as Potential Chemopreventive Agents against Tobacco-Induced Lung Carcinogenesis. Nutrients. 15(3). 491–491. 11 indexed citations

11.

Song, Zhiqiang, Gusheng Tang, Chunlin Zhuang, et al.. (2022). Metabolomic profiling of cerebrospinal fluid reveals an early diagnostic model for central nervous system involvement in acute lymphoblastic leukaemia. British Journal of Haematology. 198(6). 994–1010. 6 indexed citations

12.

Li, Tengfei, et al.. (2022). Homobivalent, Trivalent, and Covalent PROTACs: Emerging Strategies for Protein Degradation. Journal of Medicinal Chemistry. 65(13). 8798–8827. 32 indexed citations

13.

Zhao, Wenli, Yue Liu, Lijuan Xu, et al.. (2022). Targeting Necroptosis as a Promising Therapy for Alzheimer’s Disease. ACS Chemical Neuroscience. 13(12). 1697–1713. 18 indexed citations

14.

Xia, Chun‐Nian, et al.. (2021). Structure-based bioisosterism design of thio-benzoxazepinones as novel necroptosis inhibitors. European Journal of Medicinal Chemistry. 220. 113484–113484. 25 indexed citations

15.

Dong, Yuesheng, Na Yu, Xia Li, et al.. (2020). Dietary 5,6,7-Trihydroxy-flavonoid Aglycones and 1-Deoxynojirimycin Synergistically Inhibit the Recombinant Maltase–Glucoamylase Subunit of α-Glucosidase and Lower Postprandial Blood Glucose. Journal of Agricultural and Food Chemistry. 68(33). 8774–8787. 24 indexed citations

16.

Liu, Yue, Hui Wang, Ning Liu, et al.. (2019). Oxymatrine protects neonatal rat against hypoxic-ischemic brain damage via PI3K/Akt/GSK3β pathway. Life Sciences. 254. 116444–116444. 30 indexed citations

17.

Meng, Ning, Hua Tang, Hao Zhang, et al.. (2018). Fragment-growing guided design of Keap1-Nrf2 protein-protein interaction inhibitors for targeting myocarditis. Free Radical Biology and Medicine. 117. 228–237. 33 indexed citations

18.

Chen, Long, Chunlin Zhuang, Junjie Lu, Yan Jiang, & Chunquan Sheng. (2018). Discovery of Novel KRAS-PDEδ Inhibitors by Fragment-Based Drug Design. Journal of Medicinal Chemistry. 61(6). 2604–2610. 26 indexed citations

19.

Zhuang, Chunlin, Wen Zhang, Chunquan Sheng, et al.. (2017). Chalcone: A Privileged Structure in Medicinal Chemistry. Chemical Reviews. 117(12). 7762–7810. 1105 indexed citations breakdown →

20.

Jiang, Yan, Chunlin Zhuang, Long Chen, et al.. (2017). Structural Biology-Inspired Discovery of Novel KRAS–PDEδ Inhibitors. Journal of Medicinal Chemistry. 60(22). 9400–9406. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact